KOSDAQBatteries101360

Eco&Dream

₩7,110▼ 4.18%2026-11-18 close
Market Cap
₩126.5B
Turnover
₩800M
Volume
120K
Shares out.
17.8M
PER
—
PBR
0.8×
EPS
-₩1,625
Dividend Yield
0.00%

PER, EPS, PBR and BPS are calculated in-house from the last 4 quarters (2025Q4–2026Q3) · Dividend yield is based on ₩0 per share · Prices as of the 2026-11-18 close

01

Report overview

Volumes Rising, Losses Persisting at a Precursor Maker

Sales have risen for two straight quarters through 2026 Q3, but operating losses have continued for four consecutive quarters, so the timing of margin recovery is the next checkpoint.

  1. 1

    Annual sales have grown for two consecutive years since the 2023 low, and 2025 is the largest year in the 2022 to 2025 period.

  2. 2

    2026 Q3 sales were KRW 25.7 billion, down 26.4% from a year earlier, and operating results swung into a loss.

  3. 3

    The company has posted losses for four consecutive quarters from 2025 Q4 to 2026 Q3, and the KRW 11.9 billion operating loss in 2026 Q3 is the largest loss among the five quarters on record.

  4. 4

    A KRW 35 billion convertible bond was fully paid in October 2026, and the company said the proceeds will fund precursor raw material purchases.

  5. 5

    The company expects 2026 Q4 sales to grow year on year and cites supply contracts totaling KRW 38.7 billion signed over two months.

02

Business structure

Eco&Dream is a battery materials company whose core business is precursor cathode active materials, the raw material for the cathode in lithium-ion batteries, and it also runs an environmental catalyst business. Precursors are reported to account for 60 to 70 percent of cathode material cost.

According to company disclosures, the secondary battery materials segment generated KRW 20 billion in 2025 Q1, or 67% of total sales, and precursor sales reached KRW 61.2 billion in 2024, more than half of annual sales of KRW 104.9 billion.

The catalyst segment generates steady revenue because demand for catalysts used in internal combustion engine emission standards occurs on an ongoing basis.

Production sits at the Cheongju plant, with 5,000 tons a year, and the Saemangeum Campus in Jeonbuk, with 30,000 tons a year, giving a combined capacity of 35,000 tons.

Saemangeum began NCM precursor mass production and shipments in late July 2026, and the company plans to expand capacity in stages to 100,000 tons a year by 2030. Its main customer includes Belgium's Umicore, and the company says its precursors reach electric vehicles of global automakers through that network.

Its core product is high-nickel NCM precursor with nickel content above 90%, and the lineup is expanding to LMR, HVM and LFP. Chinese companies have led the precursor market, and the company positions itself as a non-Chinese supplier. Export share rose from 4.7% of sales in 2023 to 63.4% in 2025 Q3.

03

Earnings trend

Quarterly revenue · Operating profit
RevenueOperating profit
Annual revenue · Operating profit
RevenueOperating profit
Quarterly results · Last 5 quarters
QuarterRevenueOperating profitOp. margin
2025Q3₩35B₩300M0.9%
2025Q4₩37.3B-₩1B−2.8%
2026Q1₩16.2B-₩800M−4.7%
2026Q2₩20.2B-₩5.3B−26.1%
2026Q3₩25.7B-₩11.9B−46.2%
Annual results
YearRevenueOperating profitNet income (parent)Op. marginROEDebt-to-equity
2022₩60.5B₩2.3B₩95,215,2433.7%0.1%75.4%
2023₩51.5B-₩3B-₩10.2B−5.8%−10.1%52.9%
2024₩104.9B₩500M₩13.5B0.5%6.1%83.1%
2025₩142B-₩600M-₩8.6B−0.4%−4.0%117.5%

Consolidated basis (financial statements including subsidiaries) · Final figures from DART filings · Net income attributable to owners of the parent · Data as of 2026-11-13

04

Earnings analysis

On a disclosed annual basis, sales fell from KRW 60.5 billion in 2022 to KRW 51.5 billion in 2023, a 15.0% decline, then rose to KRW 104.9 billion in 2024, up 103.9%, and to KRW 142 billion in 2025, up 35.3%. 2023 was the low point, and sales grew for two consecutive years from 2024 through 2025, with 2025 the largest year in the 2022 to 2025 period.

The operating margin went from 3.7% in 2022 to -5.8% in 2023, then 0.5% in 2024 and -0.4% in 2025. Operating profit turned positive in 2024 at KRW 487 million, but profit attributable to controlling shareholders was KRW 13.5 billion, far larger than operating profit.

That gap comes from non-operating items, and the line items should be checked in the notes to the annual report's income statement. In 2025 the company returned to an operating loss of KRW 610 million and a net loss attributable to controlling shareholders of KRW 8.6 billion.

On a quarterly basis, 2025 Q3 sales of KRW 35 billion with operating profit of KRW 323 million gave way to KRW 37.3 billion in sales and an operating loss of KRW 1.04 billion in Q4.

Sales dropped to KRW 16.2 billion in 2026 Q1, then rose to KRW 20.2 billion in Q2 and KRW 25.7 billion in Q3, two straight quarters of growth. Operating losses widened over the same stretch, reaching KRW 764 million in Q1, KRW 5.28 billion in Q2 and KRW 11.9 billion in Q3.

Per the company's own announcement, precursor sales in Q3 reached KRW 17.8 billion, which exceeded the first-half total of KRW 17.3 billion in a single quarter, but weak demand and fixed costs kept the company in the red.

The net loss attributable to controlling shareholders for the four quarters from 2025 Q4 to 2026 Q3 totals KRW 28.6 billion. Operating cash flow was negative at KRW -21.9 billion in 2024 and KRW -11.1 billion in 2025, and the debt ratio rose to 117.5% at the end of 2025 from 75.4% in 2022.

05

Industry analysis

Precursors account for 60 to 70 percent of cathode material cost, so the business is tied directly to cathode demand and raw material flows.

Under the Prohibited Foreign Entity provisions in the One Big Beautiful Bill Act in the United States, the use of Chinese-made precursors is restricted, and the company and press reports say this has created demand for non-Chinese suppliers.

The company argues that under this regulatory environment, technology and operating independence matter as much as plant location in supply chain reviews. Demand for North American electric vehicles fell after subsidies ended, and the company describes the market as now showing signs of recovery.

The company is building its production and product plans around a recovery in the secondary battery cycle in 2027.

Because Chinese companies have led the precursor market, pricing and yield competition remain key variables, and the company points to its proprietary technology in supplying precursors tailored to customer specifications.

Recognition at the 2026 InterBattery Awards for a high-nickel precursor with nickel content above 90 percent is cited as evidence of its technology position.

Expansion of precursor capacity depends on customers' cathode production plans, raw material prices and early-stage yields, so demand timing and utilization need to be tracked together. The timing and strength of the recovery are management's own view and should be read alongside external demand indicators.

06

Outlook

The company defined 2026 as a Build Year, aimed at consolidating its internal systems, and in June 2026 said it was adding finance and HR staff to tighten profitability and cost management.

The company set a goal of a gradual sales recovery from 2026 Q3, in line with a recovery in the North American electric vehicle market. For Q4, the company expects year-on-year growth and cites high-nickel NCM precursor supply contracts totaling KRW 38.7 billion signed over two months.

That contract amount exceeds 2025 Q4 sales of KRW 37.3 billion. Reports say additional supply volumes are scheduled for December 2026. In October 2026, the company said its annual precursor shipments in 2027 would reach their highest level since its founding.

Utilization at the Saemangeum Campus is the key production variable, and the company says fixed costs added during startup should ease as utilization rises.

On the product side, the company became the first domestic precursor maker to start LFP precursor development, is building equipment at its Ochang Innovation Center, and plans to complete a pilot line in 2027 for customer evaluation.

Sulfide-based solid electrolyte and lithium sulfide for all-solid-state batteries remain at the research and review stage, with business plans to be announced separately. The company has laid out a medium-term plan for 100,000 tons of annual capacity by 2030.

The next checkpoints are whether 2026 Q4 sales grow year on year and whether quarterly operating losses start to narrow.

07

Valuation

PER
—
PBR
0.8×
ROE
-13.7%
EPS
-₩1,625
BPS
₩11,038
Dividend per share
₩0

Price-to-earnings cannot be calculated because the company posted net losses for four consecutive quarters from 2025 Q4 to 2026 Q3. Price-to-book sits below 1x, meaning the stock trades below book value per share.

Of total equity of KRW 213.7 billion at the end of 2025, KRW 213.5 billion is attributable to controlling shareholders. A discount to net assets does not by itself indicate direction for the share price, and book value carries limited meaning while operating losses continue.

No dividend has been confirmed, and in March 2026 the company announced a plan to pay employees partly in restricted stock units funded by treasury shares. Because that plan replaces part of salary with equity, it is relevant when reviewing shareholder returns and compensation together.

Earnings in profitable years have swung widely, as with net profit attributable to controlling shareholders of KRW 13.5 billion in 2024, so past multiple bands are difficult to apply directly to current earnings.

Compared with market capitalization, the KRW 35 billion convertible bond is not small, so the potential dilution from conversion should also be considered.

PER, EPS, PBR and BPS are all calculated in-house (the same method as Naver and Toss) · Dividend yield = cash dividend per share from DART filings (supplemented by KRX) ÷ current price · As of 2026-11-13

08

Bull factors

Regulation and North American Demand Align

U.S. Prohibited Foreign Entity rules restrict Chinese-made precursors, creating demand for non-Chinese suppliers. As North American electric vehicle demand shows signs of recovery, company disclosures say 2026 Q3 precursor sales of KRW 17.8 billion exceeded the first-half total of KRW 17.3 billion in a single quarter. The company expects this trend to continue beyond Q4.

Supply Contracts and Volume Visibility

Contracts disclosed by the company for high-nickel NCM precursor total KRW 38.7 billion over two months, exceeding 2025 Q4 sales of KRW 37.3 billion. Reports say additional volumes are scheduled for December 2026. Citing these contracts, the company expects 2026 Q4 sales to grow year on year.

Capacity and Product Lineup Expansion

Combined capacity at Cheongju at 5,000 tons and Saemangeum at 30,000 tons reaches 35,000 tons a year. The company is broadening its product range to LMR, HVM and LFP, and its high-nickel precursor above 90 percent nickel content received recognition at the 2026 InterBattery Awards. The export share reached 63.4% in 2025 Q3.

09

Bear factors

Four Straight Operating Losses and Wider Losses

The company has posted operating losses for four consecutive quarters from 2025 Q4 to 2026 Q3, and the operating loss widened from KRW 5.28 billion in Q2 to KRW 11.9 billion in Q3. The net loss attributable to controlling shareholders over the four quarters totals KRW 28.6 billion. Although sales grew for two straight quarters, profit and loss did not improve in step.

Lower Sales and Chinese Competition

2026 Q3 sales were KRW 25.7 billion, down 26.4% year on year. The company attributed continued losses to weak demand. The precursor market has been led by Chinese companies, and the company's position in pricing and yield competition is not yet confirmed in quarterly results.

Financial Burden and Convertible Bond Dilution

The debt ratio rose to 117.5% at the end of 2025 from 75.4% in 2022. Operating cash flow was negative at KRW -21.9 billion in 2024 and KRW -11.1 billion in 2025. The KRW 35 billion convertible bond carries 0% coupon and maturity interest, but conversion would increase the share count and dilute existing shareholders.

10

Risk factors

Policy and Demand Risk

Changes in the interpretation of U.S. PFE rules and tax legislation could alter the strength of demand for non-Chinese precursors. If North American electric vehicle demand recovers later than the company expects, utilization and the sales recovery timeline would both slip. The company's plans assume a 2027 cycle recovery, so a delay would have a large effect.

Financial and Funding Risk

The debt ratio stood at 117.5% at the end of 2025, and operating cash flow was negative in both 2024 and 2025. The KRW 35 billion convertible bond has a conversion price set 10% above the reference share price, with no adjustment if the share price falls.

The company said proceeds will fund raw material purchases, so the use of funds should be tracked alongside results.

Business and Technology Risk

New products including LFP, LMR and HVM are still in development and evaluation, and the LFP pilot line is targeted for completion in 2027. All-solid-state related work is at the research and review stage, so commercialization timing is uncertain.

Because precursors make up a large share of cathode cost, any delay in product transition would leave existing products exposed to price competition.

11

What to watch next

  1. December 2026

    Confirm whether the additional supply volumes ship on schedule. How much of the KRW 38.7 billion in contracts shows up in Q4 sales will determine whether sales grow year on year.

  2. Late March 2027 (deadline for the FY2026 annual report)

    Check the FY2026 results and 2026 Q4 figures in the annual report on DART. The key questions are whether the four-quarter operating loss streak ends and what drives the gap between operating profit and net profit attributable to controlling shareholders.

  3. Mid-May 2027 (deadline for the 2027 Q1 quarterly report)

    Check whether 2027 Q1 sales exceed the 2026 Q3 level of KRW 25.7 billion and whether operating losses start to narrow. It is the first quarter in which the utilization gains at Saemangeum should show clearly.

  4. During 2027

    Confirm completion of the LFP precursor pilot line and the start of customer evaluations. Whether domestic LFP precursor production actually comes online is the test of product diversification.

  5. Late March 2028 (deadline for the FY2027 annual report)

    Check whether annual precursor shipments in 2027 reached the record level the company has targeted. Also look at whether the 2027 operating margin returns to positive territory.

12

Overall view

Eco&Dream's annual sales grew in both 2024 and 2025 after the 2023 low, and 2025 was the largest year in the 2022 to 2025 period. Operating losses, however, have continued for four consecutive quarters from 2025 Q4 to 2026 Q3, and the 2026 Q3 operating loss widened to KRW 11.9 billion.

Sales rose for two straight quarters in 2026 Q2 and Q3 but have not yet translated into better profitability. Positive factors include demand for non-Chinese precursors under U.S. PFE rules, supply contracts totaling KRW 38.7 billion, and a 30,000-ton production base at Saemangeum.

Negative factors include widening operating losses, a debt ratio of 117.5%, negative operating cash flow and possible dilution from the KRW 35 billion convertible bond. The company projects a cycle recovery in 2027 and record annual shipments, and whether these are achieved is the central checkpoint.

The next checkpoints are the 2026 Q4 and FY2026 results, the gap between operating and net profit, and the 2027 Q1 quarterly results.

13

Sources

  1. Korea Exchange (KRX) — Prices · Market Cap · Volume
  2. FSS electronic disclosure system (DART) — Financial statements · Dividend filings
Show 18 more articles and sources
  1. fnnews.com
  2. zdnet.co.kr
  3. endss.com
  4. finance-scope.com
  5. endss.com
  6. thelec.kr
  7. endss.com
  8. endss.com
  9. endss.com
  10. thelec.kr
  11. fnnews.com
  12. newspim.com
  13. endss.com
  14. endss.com
  15. news.nate.com
  16. job-post.co.kr
  17. en.fnnews.com
  18. zdnet.co.kr

Report written 2026-11-14 · Data as of 2026-11-13

This content is AI analysis of market data and web search results, provided for information only. It is not a solicitation or recommendation to invest. Investment decisions and their consequences are the investor's own responsibility. Data may be delayed or contain errors.

Other reports in this industry

View industry analysis